INDV

Indivior Pharmaceuticals Inc NASDAQ Listed Dec 29, 2014

Healthcare ·Drug Manufacturers - Specialty & Generic ·US · indivior.com

$39.60

Mkt Cap $4.9B

52w Low $10.63 95.4% of range 52w High $41.00

50d MA $32.37 200d MA $29.65

P/E (TTM) 22.4x

EV/EBITDA 15.3x

P/B —

Debt/Equity -3.6x

ROE -214.3%

P/FCF -48.2x

RSI (14) —

ATR (14) —

Beta 1.21

50d MA $32.37

200d MA $29.65

Avg Volume 2.4M

Indivior Pharmaceuticals Inc is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.

SIC Code

2834

CIK (SEC)

1625297

Phone

804 379 1090

10710 Midlothian Turnpike · North Chesterfield, VA 23235 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 30, 2026	BMO	0.64	0.96	+50.0%	34.15	+5.3%	+7.7%	+2.4%	+3.5%	+1.6%	+2.6%	—
Feb 26, 2026	BMO	0.65	0.82	+26.2%	33.63	+2.6%	+0.2%	-2.9%	-2.3%	-3.5%	+4.2%	—
Oct 30, 2025	BMO	0.38	0.72	+89.5%	25.24	+18.9%	+15.4%	+0.8%	+6.2%	+2.6%	+0.2%	—
Jul 31, 2025	BMO	0.26	0.51	+96.2%	17.40	+19.9%	+16.1%	+4.2%	+0.8%	+2.7%	+0.9%	—
Apr 24, 2025	BMO	0.22	0.41	+86.4%	9.45	+10.1%	+13.9%	+7.4%	+0.1%	+1.6%	-2.0%	—
Feb 20, 2025	BMO	0.32	0.32	+0.0%	10.91	-17.7%	-17.6%	-6.0%	-2.4%	+0.1%	+3.9%	—
Oct 24, 2024	BMO	0.31	0.54	+74.2%	8.56	+6.5%	+2.5%	+2.6%	-0.9%	+2.7%	+1.5%	—
Jul 25, 2024	BMO	0.40	0.44	+10.0%	10.88	+16.5%	+20.3%	-2.3%	+2.0%	+4.7%	+0.7%	—
Apr 25, 2024	BMO	0.42	0.37	-11.9%	18.81	-4.6%	-8.3%	+1.9%	+2.0%	-2.1%	+0.4%	—
Feb 22, 2024	BMO	0.28	0.43	+53.6%	17.50	+14.6%	+21.7%	-0.1%	+0.6%	+4.0%	-1.6%	—
Nov 9, 2023	BMO	0.30	0.34	+13.3%	19.30	-6.7%	-5.5%	-12.5%	-1.5%	+11.1%	+1.8%	—
Jul 27, 2023	BMO	0.22	0.39	+77.3%	24.39	-1.6%	-3.6%	-3.1%	-2.4%	+2.3%	-0.5%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Jan 12	HC Wainwright & Co.	Maintains	Buy → Buy	—	$35.44	$36.22	+2.2%	-2.5%	-1.6%	-1.1%	-2.2%	-1.1%
Oct 31	Piper Sandler	Maintains	Overweight → Overweight	—	$29.13	$29.68	+1.9%	+0.8%	+6.2%	+2.6%	+0.2%	-0.6%
Oct 30	HC Wainwright & Co.	Maintains	Buy → Buy	—	$25.24	$30.00	+18.9%	+15.4%	+0.8%	+6.2%	+2.6%	+0.2%
Aug 27	Craig-Hallum	Maintains	Buy → Buy	—	$24.46	$24.90	+1.8%	-0.4%	-2.0%	+1.7%	+1.3%	+0.3%
Jun 30	Craig-Hallum	Maintains	Buy → Buy	—	$13.95	$14.19	+1.7%	+5.7%	-0.5%	+5.0%	+0.1%	+0.9%
Mar 6	Piper Sandler	Maintains	Overweight → Overweight	—	$10.01	$9.80	-2.1%	-1.2%	-1.9%	-1.9%	+2.6%	-0.1%
Oct 25	Piper Sandler	Maintains	Overweight → Overweight	—	$8.77	$9.16	+4.4%	+2.6%	-0.9%	+2.7%	+1.5%	-3.1%
Oct 11	Craig-Hallum	Maintains	Buy → Buy	—	$7.98	$7.63	-4.4%	-6.5%	+5.9%	+1.3%	+1.8%	+5.5%
Oct 11	Piper Sandler	Maintains	Overweight → Overweight	—	$7.98	$7.63	-4.4%	-6.5%	+5.9%	+1.3%	+1.8%	+5.5%
Sep 13	Piper Sandler	Maintains	Overweight → Overweight	—	$9.62	$9.72	+1.0%	+2.9%	-3.6%	-0.3%	+2.7%	-0.9%
Jul 10	Craig-Hallum	Maintains	Buy → Buy	—	$10.19	$9.90	-2.8%	+3.1%	+7.8%	-4.3%	-4.1%	-0.9%

Data updated apr 25, 2026 3:33pm · Source: massive.com